中国全科医学 ›› 2018, Vol. 21 ›› Issue (21): 2611-2615.DOI: 10.3969/j.issn.1007-9572.2018.00.228

• 专题研究 • 上一篇    下一篇

红蓝光照射及多磺酸粘多糖乳膏联合西黄胶囊治疗中重度面部痤疮的临床疗效及生活质量研究

马月仙1,王永琴2*,杨惠芳3,孙晶1,刘微1,邢海宁4,李琛4   

  1. 1.161006黑龙江省齐齐哈尔市,齐齐哈尔医学院附属第二医院护理部 2.161006黑龙江省齐齐哈尔市,齐齐哈尔医学院附属第二医院皮肤科 3.161006黑龙江省齐齐哈尔市,齐齐哈尔医学院附属第二医院CT室 4.150000黑龙江省哈尔滨市,黑龙江省医院皮肤科
    *通信作者:王永琴,主任医师;E-mail:2905953480@qq.com
  • 出版日期:2018-07-20 发布日期:2018-07-20
  • 基金资助:
    基金项目:黑龙江省卫生厅科研课题(2013381)——红蓝光联合药物治疗对痤疮患者生活质量改善的研究

Quality of Life Clinical Response of Moderate to Severe Facial Acne Patients to Alternating Red and Blue Light Irradiation Generated by Light Emitting Diodes,Mucopolysaccharide Polysulfate Cream and Xihuang Capsule

  1. 1.Department of Nursing,the Second Affiliated Hospital of Qiqihar Medical University,Qiqihar 161006,China
    2.Department of Dermatology,the Second Affiliated Hospital of Qiqihar Medical University,Qiqihar 161006,China
    3.CT Room,the Second Affiliated Hospital of Qiqihar Medical University,Qiqihar 161006,China
    4.Department of Dermatology,Heilongjiang Provincial Hospital,Harbin 150000,China
    *Corresponding author:WANG Yong-qin,Chief physician;E-mail:2905953480@qq.com
  • Published:2018-07-20 Online:2018-07-20

摘要: 目的 探讨红蓝光照射、多磺酸粘多糖乳膏联合西黄胶囊治疗中重度面部痤疮的临床疗效及对生活质量的影响。方法 选取2015年12月—2016年12月齐齐哈尔医学院附属第二医院和黑龙江省医院收治的中重度面部痤疮患者300例。采用随机数字表法将其分为A、B、C组,各100例。C组患者采用传统红蓝光照射治疗,B组患者在C组基础上加用多磺酸粘多糖乳膏治疗,A组患者在红蓝光照射及多磺酸粘多糖乳膏治疗基础上联合应用西黄胶囊治疗。比较3组患者临床疗效,治疗前后炎性皮损、非炎性皮损数目,IgG、IgA、IgM,补体C3、C4,白介素(IL)-2、可溶性白介素2受体(sIL-2R)水平,性激素〔血清促卵泡生成素(FSH)、黄体生成素(LH)、睾酮(T)、雌二醇(E2)〕水平以及生活质量评价量表(SF-36)评分。结果 A组患者临床疗效优于B、C组(P<0.05)。治疗后A组患者炎性皮损、非炎性皮损数目少于B、C组(P<0.05)。治疗后3组患者炎性皮损、非炎性皮损数目均较治疗前减少(P<0.05)。治疗后A组IgG、C3、C4、IL-2水平低于B、C组(P<0.05)。治疗后A组IgG、C3、C4、IL-2水平低于治疗前(P<0.05)。3组男性和女性患者治疗前、后性激素水平组间比较,差异无统计学意义(P>0.05)。治疗后A组患者SF-36评分高于B、C组,B组SF-36评分高于C组(P<0.05)。结论 红蓝光照射、多磺酸粘多糖乳膏联合西黄胶囊治疗中重度面部痤疮疗效显著,能够改善患者的免疫功能,并且对提升患者生活质量具有积极作用。

关键词: 寻常痤疮, 物理治疗技术, 药物疗法, 联合, 治疗结果

Abstract: Objective  To discuss the clinical efficacy of alternating red and blue light irradiation generated by light emitting diodes(ARBLIGLED),Mucopolysaccharide Polysulfate Cream(MPC) and Xihuang Capsule(XC) for moderate to severe facial acne,and to investigate the degree of improvement in quality of life in these patients.Methods We enrolled 300 cases of moderate to severe facial acne from the Second Affiliated Hospital of Qiqihar Medical University and Heilongjiang Provincial Hospital from December 2015 to December 2016.Using random number table,we divided them into group A,group B and group C,with 100 in each,treated by ARBLIGLED combined with MPC and XC,ARBLIGLED combined with MPC,ARBLIGLED,respectively.Indicators for clinical efficacy include the number of inflammatory and non-inflammatory skin lesions,and levels of IgG,IgA,IgM,serum complement C3 and C4,IL-2,sIL-2R,and 4 sex hormones(follicle-stimulating hormone,luteinizing hormone,testosterone,estradiol).Quality of life was assessed by SF-36.Results After treatment,the number of both inflammatory and non-inflammatory skin lesions decreased significantly in all groups compared with baseline(P<0.05);levels of IgG,C3,C4 and IL-2 were found to be significantly lower in group A(P<0.05);the levels of 4 sex hormones were still similar in males or females of all groups(P>0.05).Compared with other two groups,after treatment,group A achieved better clinical response,which was indicated by much less number of inflammatory and non-inflammatory skin lesions,and significantly lower levels of IgG,C3,C4 and IL-2(P<0.05).After treatment,group A achieved the highest SF-36 scores,followed by groups B and C(P<0.05).Conclusion The combination regimen of ARBLIGLED,MPC and XC has significant effect on moderate to severe facial acne as indicated by much improved immune functions and quality of life.

Key words: Acne vulgaris;Physical therapy modalities;Drug therapy, combination;Treatment outcome